These results suggest that the pharmacological effects of EH on the inhibition of the abnormal proliferation of HCC and the promotion of HCC cell apoptosis are achieved by regulating the PI3K-AKT signaling pathway. The gene discussed is AKT1; the disease is hepatocellular carcinoma.